Home >  News >  October, 2008

FDA Issues Surgical Mesh Warning

Agency has received reports of complications following two commonly performed GYN procedures.

Published: October 24, 2008

Surgical mesh used to treat pelvic organ prolapse and stress urinary incontinence can cause severe complications when placed through incisions in the vagina, according to a warning issued by the Food and Drug Administration. Potential complications include erosion of the vagina’s wall, infection, pain, urinary problems and recurrence of the prolapse or incontinence.

The FDA has also received reports of mesh erosion causing scarring of the vagina, which led to discomfort and pain during sexual intercourse and required additional surgery to remove mesh that had eroded into the vagina.

Daniel Cook


Also in the News...

Music Is as Good as Sedative in Calming Nerves Before Surgery
Jury: Orthopedic Surgeon's Routine of Performing 14 Concurrent Surgeries a Day Negligent
Federal Court Dismisses More Than 5,000 Lawsuits Against 3M's Patient Warming System
Study Finds Sedation Method Doesn't Affect Adenoma Detection Rate
Negligence Suit: Reckless Intraoperative Neuromonitoring During Spinal Surgery Led to Deadly Catastrophic Hypoxic Brain Injury
Class Action: 600 Ex-employees Sue Laser Spine Institute for 2 Months of Pay and Benefits
Senator Creates Firestorm With Nurses Playing Cards Comment

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You